NSE ScannerComparison · NSE · data 2026-11-01
3B BlackBio Dx Ltd vs Astec Lifesciences Limited
In plain words
Size: Astec Lifesciences Limited is about 1.1 times the market value of 3B BlackBio Dx Ltd.
Return on equity: 3B BlackBio Dx Ltd 20.2% vs Astec Lifesciences Limited -25.9%.
Debt to equity: Astec Lifesciences Limited 1.15 vs 3B BlackBio Dx Ltd 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| 3BBLACKBIO | ASTEC | |
|---|---|---|
| Price | ₹1,295.7 | ₹545.55 |
| Market cap | ₹1,113 cr | ₹1,218 cr |
| P/E | 20 | — |
| P/B | — | 3.6 |
| ROE | 20.2% | -25.9% |
| ROCE | 17.1% | -9.8% |
| Debt / equity | 0.01 | 1.15 |
| Operating margin | 30.9% | -12.0% |
| Dividend yield | 0.39% | 0.00% |
| Sales growth, 3 years (yearly) | 31.9% | -10.7% |
| Profit growth, 3 years (yearly) | 32.2% | — |
| 1-year return | -2.5% | -18.6% |
| Revenue, last 12 months | ₹153 cr | ₹439 cr |
| Net profit, last 12 months | ₹56 cr | ₹-80 cr |
| Latest quarter | — | Sept 2026 |
| Quarter net profit | — | ₹-37 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | 71.96% |
| Health check | Strong (6.5/10) | Weak (0/10) |
Common questions
Which earns a higher return on equity?
3B BlackBio Dx Ltd (20.2% against -25.9%).
Which carries more debt?
Astec Lifesciences Limited has the higher debt-to-equity ratio (1.15 against 0.01).